SOURCE: Implant Sciences

Implant Sciences

March 14, 2011 07:10 ET

Implant Sciences Announces New Distributors in Mexico, Turkey, and Cyprus

Company Continues to Aggressively Expand Global Sales Channels

WILMINGTON, MA--(Marketwire - March 14, 2011) - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced the addition of three new international distributors: Provetecnia of Mexico; Labirent of Turkey; and Omega Risk International of Cyprus.

Provetecnia S.A. de C.V. has been a leading supplier of inspection systems in Mexico since 1984. Systems include explosives trace detection, x-ray machines, and metal detectors. The company has extensive experience providing equipment to a wide variety of locations where security is paramount, and will be focusing on aviation security opportunities in Mexico.

Labirent Building Automation and Electronic Systems, Ltd. is a leader in Turkey for electronics and security in buildings. Security equipment and services include explosives trace detection and explosives removal and disarming. Labirent's clients range from the national government of Turkey to leading global corporations with facilities in Turkey such as The Coca-Cola Company. Other clients include the largest Turkish companies in pharmaceuticals, insurance, and oil. The company also serves international clients in Russia and Kazakhstan.

Cyprus-based Omega Risk International Ltd. provides security services to clients around the world. The company provides manned services, equipment, and training in numerous security fields including explosives trace detection. Omega Risk International's clients include companies in oil and gas, hotel and hospitality, as well as non-governmental organizations and public sector facilities. The company's international partnerships span the globe including security providers in Iraq.

"Around the globe, there is growing demand for security systems and equipment from both the private and public sectors. We are very pleased to provide our Quantum Sniffer explosives trace detection device to distributors that are the leaders in their geographic markets," stated Implant Sciences CEO, Glenn Bolduc.

About the Quantum Sniffer QS-H150

The QS-H150 Quantum Sniffer is a hand-held explosive trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, and homemade explosives. The QS-H150 features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 Portable Explosives Detector has been designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by governments or by other law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:

    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    CEO
    978-752-1700
    Email Contact

    or

    Investor Contact:
    Laurel Moody
    646-810-0608
    Email Contact